BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+42%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.04B
AUM Growth
+$7.04B
(+39%)
Cap. Flow
-$184M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
79.89%
Holding
87
New
12
Increased
14
Reduced
15
Closed
5
Top Buys
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$243M |
| 2 |
VPHM
VIROPHARMA INC
VPHM
|
$115M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$13.6M |
| 4 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$8.92M |
| 5 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$7.49M |
Sector Composition
| 1 | Healthcare | 42.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
| $1.25B | 17.71% | 9,010,211 -1,760,927 | -16% | -$243M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $847M | 12.04% | 19,322,947 | – | – |
|
|
GEVA
3
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $651M | 9.26% | 10,273,182 +1,050,000 | +11% | +$66.6M |
|
4
Incyte
INCY
$16.5B
| $565M | 8.03% | 14,810,559 | – | – |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $548M | 7.79% | 19,955,126 | – | – |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $417M | 5.93% | 13,650,835 | – | – |
|
|
VPHM
7
DELISTED
VIROPHARMA INC
VPHM
| $220M | 3.12% | 5,592,239 -2,936,364 | -34% | -$115M |
|
8
Xoma
XOMA
$392M
| $103M | 1.47% | 23,032,372 +2,757,791 | +14% | +$12.4M |
|
9
Gilead Sciences
GILD
$140B
| $78.3M | 1.11% | 1,245,800 | – | – |
|
10
Halozyme
HALO
$8.56B
| $77.5M | 1.1% | 7,017,608 +464,458 | +7% | +$5.13M |
|
|
RPRX
11
DELISTED
Repros Therapeutics Inc.
RPRX
| $74.5M | 1.06% | 2,778,654 | – | – |
|
|
AEGR
12
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $70.3M | 1% | 820,275 -104,068 | -11% | -$8.92M |
|
13
Cerus
CERS
$251M
| $56.8M | 0.81% | 8,455,306 | – | – |
|
14
BioMarin Pharmaceuticals
BMRN
$11.2B
| $56.5M | 0.8% | 783,311 | – | – |
|
15
Vanda Pharmaceuticals
VNDA
$279M
| $52.5M | 0.75% | 4,791,179 +825,000 | +21% | +$9.03M |
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $48.8M | 0.69% | 6,699,979 +1,136,364 | +20% | +$8.27M |
|
|
STML
17
DELISTED
Stemline Therapeutics, Inc.
STML
| $36.3M | 0.52% | 800,400 -99,600 | -11% | -$4.51M |
|
|
DSCI
18
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $31.7M | 0.45% | 2,558,857 +1,200,000 | +88% | +$14.9M |
|
|
QCOR
19
DELISTED
QUESTCOR PHARMA INC
QCOR
| $31.7M | 0.45% | 545,846 +230,000 | +73% | +$13.3M |
|
|
MRTX
20
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $30M | 0.43% | +1,980,074 | New | +$30M |
|
|
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $25M | 0.36% | 362,847 -100,000 | -22% | -$6.9M |
|
|
ARIA
22
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $24.5M | 0.35% | 1,333,703 -116,297 | -8% | -$2.14M |
|
|
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
| $23.9M | 0.34% | 398,331 | – | – |
|
|
PGNX
24
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $21.1M | 0.3% | 4,200,000 | – | – |
|
|
AVNR
25
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $18.7M | 0.27% | 4,428,591 +850,000 | +24% | +$3.6M |
|